| Fiscal Year End | Company Status | Exempt Flag |
| September 30 | Trading | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 28/Apr/2004 | | Canada | Ontario | |
|
|
| Exchange Filing Office |
| Location |
| Toronto Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Research and Development of Biomaterials and Biomedical Products
| From News Release June 14, 2013 - Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon's technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. To learn more about Covalon, visit our website at www.covalon.com
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| COV | Covalon Technologies Ltd. | TSX Venture | TRADING |
|
|
| Name History | From | To |
| Covalon Technologies Ltd. | 24/Dec/2004 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
